NCT02022345

Brief Summary

To evaluate the introduction of Percutaneous Coronary Intervention without Onsite Surgery in the largest state, California (CA) began a pilot PCI program in 6 hospitals without onsite cardiac surgery and then compared the PCI results in the pilot hospitals with results in 120 non-pilot hospitals. The pilot program qualification incorporated appropriate planning and rigorous hospital, operator, patient, and lesion selection criteria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,609

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
Completed

Started Aug 2010

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

December 17, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 27, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

May 30, 2017

Status Verified

May 1, 2017

Enrollment Period

4.3 years

First QC Date

December 17, 2013

Last Update Submit

May 24, 2017

Conditions

Keywords

Percutaneous Coronary InterventionCoronary Artery DiseaseAngioplastyOffsite cardiac surgeryHeart diseaseIschemic Heart Disease

Outcome Measures

Primary Outcomes (1)

  • Composite safety endpoint (death, stroke, need for emergent CABG)

    The number of subjects who had death, stroke or a need emergent CABG as a result of having PCI procedure performed.

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

Secondary Outcomes (2)

  • Composite efficacy endpoint (<20% residual stenosis and post TIMI-3 flow)

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

  • AOC composite endpoint (in-hospital death and/or need for emergent CABG)

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

Other Outcomes (5)

  • In-hospital death

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

  • Stroke

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

  • Need for emergent CABG

    participants will be followed for the duration of hospital stay, an expected average of 3 days.

  • +2 more other outcomes

Study Arms (2)

PCI at pilot hospitals

ACTIVE COMPARATOR

Percutaneous Coronary Interventions performed at pilot hospitals which do not have onsite cardiac surgery.

Procedure: Percutaneous Coronary Intervention

PCI at non-pilot hospitals

ACTIVE COMPARATOR

Percutaneous Coronary Intervention performed at non-pilot hospitals which have onsite cardiac surgery or perform only primary PCIs for STEMI patients.

Procedure: Percutaneous Coronary Intervention

Interventions

Also known as: Coronary Angioplasty, Simple Angioplasty
PCI at non-pilot hospitalsPCI at pilot hospitals

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • clinically and angiographically significant coronary artery disease
  • ability to perform PCI with equipment available at the local site
  • not high-risk patient with a not high-risk lesion
  • not high-risk patient with a high-risk lesion
  • high-risk patient with a not high-risk lesion may be included in the pilot program upon confirmation that a cardiac surgeon and an operating room are immediately available if necessary

You may not qualify if:

  • high-risk patient with a high-risk lesion
  • need for coronary artery bypass surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Clovis Community Medical Center

Clovis, California, 93611, United States

Location

St Rose Hospital

Hayward, California, 94545, United States

Location

Los Alamitos Medical Center

Los Alamitos, California, 90720, United States

Location

Sutter Roseville Medical Center

Roseville, California, 95661, United States

Location

Doctors Medical Center

San Pablo, California, 94806, United States

Location

Kaiser Foundation Hospital Walnut Creek

Walnut Creek, California, 94596, United States

Location

MeSH Terms

Conditions

Coronary Artery DiseaseHeart DiseasesMyocardial Ischemia

Interventions

Percutaneous Coronary InterventionAngioplasty, Balloon

Condition Hierarchy (Ancestors)

Coronary DiseaseCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresAngioplastyCatheterizationTherapeuticsInvestigative Techniques

Study Officials

  • William J Bommer, MD

    UC Davis Health System

    PRINCIPAL INVESTIGATOR
  • Rohit Sundrani, MD

    Clovis Community Medical Center

    PRINCIPAL INVESTIGATOR
  • Stephen Arnold, MD

    Doctors Medical Center, San Pablo

    PRINCIPAL INVESTIGATOR
  • Sushil Karmarkar, MD

    Kaiser Permanente

    PRINCIPAL INVESTIGATOR
  • Steven Forman, MD

    Los Alamitos Medical Center

    PRINCIPAL INVESTIGATOR
  • Aditya Jain, MD

    St Rose Hospital, Hayward

    PRINCIPAL INVESTIGATOR
  • George Fehrenbacher, MD

    Sutter Roseville Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2013

First Posted

December 27, 2013

Study Start

August 1, 2010

Primary Completion

December 1, 2014

Study Completion

February 1, 2015

Last Updated

May 30, 2017

Record last verified: 2017-05

Locations